Status:
COMPLETED
Study of Effectiveness and Safety of Extracorporeal Shock Wave Therapy (ESWT) for Treatment of Painful Heel Syndrome
Lead Sponsor:
Storz Medical AG
Conditions:
Plantar Fasciitis
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine if the Storz Duolith SD1 is more effective than placebo for treatment of heel pain syndrome for patients who have failed conservative treatment with other the...
Eligibility Criteria
Inclusion
- Age greater than 18 years
- ability of subject or legal respondent to give written informed consent
- signed informed consent
- diagnosis of painful heel syndrome
- 6 months of unsuccessful conservative treatment
- washout from conservative treatment
- scores of 5 or greater on three VAS scales
- score of 3 or 4 on Roles and Maudsley Scale
- willingness to refrain from specified concomitant therapies
- willingness to keep subject diaries
- negative urine pregnancy test (if applicable) required use of contraception (if applicable)
Exclusion
- tendon rupture, neurological or vascular insufficiencies
- inflammation of lower and upper ankle
- history of rheumatic disease, collagen, or metabolic disorders
- history of hyperthyroidism
- active malignant disease with or without metastasis
- Paget disease or calcaneal fat pad atrophy
- osteomyelitis
- fracture of calcaneus
- immunosuppressive therapy
- long term (6 months or greater) treatment with corticosteroid
- insulin dependent diabetes, severe cardiac or respiratory disease
- coagulation disorder or therapy with anticoagulants or antiplatelet drugs
- bilateral painful heel
- planned treatment within 8 weeks of enrollment that may confound pain results
- less than required washout of other treatments
- previous surgery for painful heel
- previous unsuccessful treatment for painful heel with shock wave device
- history of allergy or hypersensitivity to local anesthetics
- significant abnormalities of hepatic function
- poor physical condition
- pregnant female
- active infection or history of chronic infection in treatment area
- history of peripheral neuropathy
- history of systemic inflammatory disease
- history of worker's compensation or litigation
- participation in study of investigational device within 30 days of selection or current active study participation
- in the opinion of the investigator, inappropriate for study inclusion
- unwilling to comply with study requirements
- implanted pacemaker, insulin pump, defibrillator, or neurostimulator
- implanted prosthetic device in area of treatment
- open wounds or skin rashes
Key Trial Info
Start Date :
June 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT00720694
Start Date
June 1 2006
Last Update
February 19 2018
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Palo Alto Medical Fondation
Palo Alto, California, United States, 94301
2
Connecticut Orthopedics Specialists
Hamden, Connecticut, United States, 06518
3
Advanced Footcare Specialists of Connecticut, LLC
Newtown, Connecticut, United States, 06470
4
Galli Podiatric Foot and Ankle Associates
New York, New York, United States, 10023